University of South Australia Team Develops New Tech to Overcome Manufacturing Bottlenecks in Blood Cancer Treatment

University of South Australia (UniSA) scientists have developed a new technique to significantly enhance Chimeric antigen receptor (CAR) T-cell therapy, a powerful treatment for leukemia and other blood cancers.

CAR T-cell therapy is an immunotherapy treatment used for patients with aggressive lymphomas. The process takes immune cells from a cancer patient, reprograms them to attack the tumor, and then reinjects them into the patient, where they bind to cancer cells and kill them.